Real-world experience of Molecular Tumour Boards for clinical decision-making for cancer patients
Abstract Molecular Tumour Boards (MTBs) play a crucial role in interpreting genomic results and providing treatment recommendations. We investigated the real-world impact of MTBs on clinical decision-making by surveying health care professionals (HCPs) across the UK; 44 participants from 11 MTBs too...
Saved in:
| Main Authors: | Julio Herrero Colomina, Eleanor Johnston, Kate Duffus, Zoulikha M. Zaïr, Fiona Thistlethwaite, Matthew Krebs, Louise Carter, Donna Graham, Natalie Cook |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-03-01
|
| Series: | npj Precision Oncology |
| Online Access: | https://doi.org/10.1038/s41698-025-00863-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A single centre experience of patients with rare cancers referred for early phase clinical trials
by: Angelos Angelakas, et al.
Published: (2025-03-01) -
Enhancing Clinical Decision-Making in LATAM through Virtual Genitourinary Tumour Boards
by: Martin Angel, et al.
Published: (2023-11-01) -
The Board President’s Role in Controlling the Decision-making Process in Voluntary Sports Organizations
by: Jorge Alexandre Pereira Soares
Published: (2016-01-01) -
Recommendations for a Communication Strategy to Support Informed Decision‐Making About Self or Clinician Sampling for Cervical Screening in the UK: Qualitative Study
by: Denitza Williams, et al.
Published: (2025-04-01) -
Use and utility of endocrine multidisciplinary tumour board: an appraisal from a tertiary centre
by: Clotilde Sparano, et al.
Published: (2025-05-01)